Neurodyn Lands $1.5M; May Add $500K
Neurodyn Inc., the Charlottetown biotech developing early treatments for neurological diseases, has closed a $1.5-million round of funding from a range of U.S. and Canadian investors and could bump the total up to $2 million.
The company will use the money to push forward with its two top candidates: NeuroPro, a dietary supplement for early-stage Parkinson’s disease, which will begin sales in Canada this year; and Progranulin, a novel therapeutic compound being developed as a treatment for ALS, Parkinson’s and Alzheimer’s diseases.
The headline investors in the round were the Regis